Skip to main content
Download PDF

Childhood glaucoma profile in a Southwestern Ethiopia tertiary care center: a retrospective study

BMC Ophthalmology volume 24, Article number: 31 (2024) Cite this article

Abstract

Background

Childhood glaucoma is a major cause of childhood blindness worldwide. The profile of childhood glaucoma has not been well characterized in sub-Saharan Africa. Thus, this study was designed to describe demographics, clinical features, managements of childhood glaucoma, and improvements in visual acuity (VA) and intraocular pressure (IOP) from baseline to final visit.

Methods

This retrospective study included glaucoma patients below 18 years old who were diagnosed between September 2019 to August 2022. Childhood glaucoma diagnosis and classification was made as per the Childhood Glaucoma Research Network Classification (CGRN).

Results

A total of 105 children (181 eyes) were diagnosed with glaucoma. The most common type of childhood glaucoma was primary congenital glaucoma (PCG) constituting (42%, n = 76 eyes, 95% confidence interval (CI), 34.7–49.5%; P = 0.037), followed by glaucoma suspect (22.1%, n = 40 eyes, 95% CI, 16.3–28.9%; P < 0.001) and juvenile open-angle glaucoma (JOAG) (15.5%, n = 28 eyes, 95% CI, 10.5–21.6%; P < 0.001). While the most common type of secondary glaucoma was steroid-induced glaucoma, followed by glaucoma following cataract surgery. Bilateral glaucoma was found in 72.4% (n = 76 children, 95% CI, 62.8–80.7%; P < 0.001) of children. In both primary and secondary glaucoma, boys were affected more than girls, in ratio of 2:1 and 2.7:1, respectively. The mean age at presentation for patients with PCG was 2.7 years. Close to 93.4% (71) of PCG eyes were managed surgically, of which majority underwent combined trabeculotomy and trabeculectomy (CTT). Most of secondary glaucoma cases were treated medically. Overall, 85.3% (111) of eyes had successful control of IOP ≤ 21 mmHg.

Conclusion

PCG was the most common type of childhood glaucoma. One of a well-recognized challenge in developing countries, late presentation of patients with PCG, was also observed in our study. Which highlights, the need of increasing access to eye-care service and awareness of childhood glaucoma as a major public health issue. Steroid-induced glaucoma was the most common type of secondary glaucoma; appropriate measures should be taken to prevent this preventable glaucoma.

Peer Review reports

Background

Childhood glaucoma is a vision threatening condition [1, 2]. World Glaucoma Association and United States Board of Ophthalmology defined childhood glaucoma as a disease onset at < 18 years of age and is characterized by intraocular pressure (IOP)-related eye damage caused by a variety of conditions [3, 4]. It is responsible for 5% of global childhood blindness and 11% of African childhood blindness [5, 6]. Despite these very large proportions, childhood glaucoma does not receive the attention it merits. In Africa, there is generally a delay in the presentation of affected children due to illiteracy in the general population, with more severe diseases phenotypes [7]. The main factors influencing its prognosis are an early, accurate diagnosis and successful IOP reduction to a level where progression is unlikely [8]. Otherwise, due to further damage to the immature visual system, the visual effects of childhood glaucoma are frequently more severe [9].

According to the CGRN classification (see Fig. 1), childhood glaucoma classified into primary glaucoma, secondary glaucoma and glaucoma suspect [4]. Primary glaucoma encompasses primary congenital glaucoma (PCG) and juvenile open-angle glaucoma (JOAG), whereas secondary glaucoma is classified based on the underlying pathology. Secondary glaucoma includes glaucoma associated with nonacquired ocular anomalies (e.g., Axenfeld-Rieger spectrum, iris hypoplasia, aniridia), glaucoma associated with nonacquired systemic disease (e.g., phacomatoses, Juvenile Idiopathic Arthritis [JIA]), and glaucoma associated with acquired conditions (e.g., uveitis, trauma, or intraocular surgery). Glaucoma following cataract surgery is classified separately [6]. Understanding the patterns and associated clinical characteristics of the various glaucoma subtypes can aid in collaborative research and the development of effective treatment and management regimens.

Fig. 1
figure 1

Childhood Glaucoma Research Network/World Glaucoma Association algorithm for the classification of childhood glaucoma. AL = axial length; C/D = cup-disc; JOAG = juvenile open-angle glaucoma; ROP = retinopathy of prematurity; VF = visual field [4]

Full size image

The purpose of this study was to provide the epidemiology, the recent classification, the clinical features, and the treatment modalities instituted and future strategies to combat childhood blindness due to glaucoma in children. Furthermore, the findings of this study address the scarcity of studies on the profile of childhood glaucoma in Sub Saharan Africa based on the CGRN classification.

Methods

We conducted a hospital-based retrospective cross-sectional study in which we reviewed and analyzed the medical records of all glaucoma patients below the age of 18 who presented to Jimma Medical Center (JMC) between September 2019 and August 2022. Medical records of patients with missing information were excluded from the study. The extracted patient data included: (1) demographics such as age at presentation, gender, consanguinity, and family history of childhood-onset glaucoma; (2) clinical data such as diagnosis according to the CGRN classification [4], laterality, visual acuity (VA) and method of testing, intraocular pressure (IOP) measurement, medications, tonometer, and details of examination under anesthesia (EUA), where applicable; and (3) management data such as medication and surgery. The best-corrected quantitative VA was converted to the equivalent logarithm of the minimum angle of resolution (logMAR) VA. If a VA assessment was not recorded, it was documented as unrecorded, and the logMAR VA was marked as missing. The following logMAR VA were assigned to certain nonquantitative visual acuities: Counting fingers = 2.10; hand motions = 2.40; light perception = 2.70; and no light perception = 3.00 [10]. All children's IOP was measured with an iCare tonometer. In young and uncooperative children IOP measured during an EUA using ketamine anesthesia. Combination eye drops were recorded as two separate medications.

Medical records with at least 6 months of follow-up data were analyzed for outcome. The definition of success was a numerical IOP ≤ 21 mmHg without (complete success) or with (qualified success) medications.

The collected data were entered into Epidata version 3.1 and extracted to SPSS version 26 for analysis. Categorical variables were summarized with numbers and percentages, while continuous variables were summarized with means and standard deviations (SDs). Differences between baseline and final visits IOP (mmHg) and VA (logMAR) were assessed using paired sample t-tests and analysis of variance when parametric statistics were appropriate and using paired Wilcoxon tests when nonparametric statistics were appropriate. P ≤ 0.05 was considered statistically significant.

The College of Medicine Research and Ethics Committee approved the study. The Institutional Review Board (IRB) determined that formal informed consent was not required because no personally identifiable information was gathered during the review of the medical records.

Results

Demographics

A total of 105 patients (181 eyes), were seen in Ophthalmology Department of JMC during the 3-year study period. Majority, 72.4% (n = 76 children, 95% CI, 62.8 – 80.7%; P < 0.001), of patients had bilateral ocular involvement. There were 62.9% (n = 66) males and 37.1% (n = 39) girls, with a mean age of 8.3 years at the time of diagnosis (SD, 6.6 years; median, 7 years).

Gender and age

Males presented with PCG at a higher rate (73.8%) than females (Table 1). The mean age at presentation for PCG patients was 2.7 years, with a SD of 3.1 years (median 1.2). While, the mean age at presentation for patients with secondary glaucoma was 8.8 years, with a SD of 4.7 years (median 9.1) (Table 2).

Table 1 Demographic Characteristics
Full size table
Table 2 Clinical Characteristics of patients with various types of childhood glaucoma
Full size table

Family history of childhood-onset glaucoma and consanguinity

A family history of childhood-onset glaucoma was found in approximately 3% of all patients. However, for most patients’ the history of consanguinity was unknown (Table 1).

Diagnosis

PCG was the most common (n = 76 eyes, 42.0%, 95% confidence interval (CI), 34.7—49.5%; P = 0.037) type childhood glaucoma, followed by glaucoma suspect (n = 40, 22.1%, 95% CI, 16.3 – 28.9%; P < 0.001) and JOAG (n = 28, 15.5%, 95% CI, 10.5 – 21.6%; P < 0.001) (Table 3). Glaucoma suspect was diagnosed in 26 (65%) eyes by suspicious optic nerve cupping and in 14 (35%) eyes by IOP > 21 mmHg. Steroid-induced glaucoma was the most common cause of secondary childhood glaucoma, accounting for 9 (5.0%) of all cases, followed by glaucoma following cataract surgery in 8 (4.4%) eyes.

Table 3 Diagnosis of Childhood Glaucoma
Full size table

Baseline visit clinical assessment

Visual acuity

Baseline visit quantitative VA was recorded in 63.0% (n = 114 eyes) of all childhood glaucoma eyes (n = 181) and in only 22.4% of PCG eyes (considering age at diagnosis). The overall mean VA of the 114 eyes that had a quantitative VA at the baseline visit was 0.92 logMAR (SD, 1.06) (Table 4).

Table 4 Baseline and Final Visit Quantitative Visual Acuity
Full size table

Intraocular pressure

Of 181 eyes with childhood glaucoma or glaucoma suspect IOP was recorded for 157 eyes. Of 76 eyes with PCG, 57 (75%) of them have baseline IOP measurements. For 9 (15.8%) of them the measurement was taken during an EUA under ketamine anesthesia. The mean IOP for all eyes was 34.6 ± 13.4 mmHg, and 41.3 ± 9.8 mmHg for PCG (Table 5).

Table 5 Baseline and Final Visit Intraocular Pressure
Full size table

Management

Primary congenital glaucoma

In this study PCG was the most common type of childhood glaucoma (76 of 181 eyes [42.0%]), its management analyzed in detail. Majority of PCG eyes (71/76, 93.4%) were treated surgically, and 6.6% received medical treatment only (n = 5 eyes) (Table 6). Among the eyes that underwent surgery, 94.4% (67/71) had anti-glaucoma medication prior to surgery, and on average, 2.04 classes of medication were prescribed (range, 1–5). The most commonly prescribed medication was a beta-blocker, followed by oral carbonic anhydrase inhibitors (CAIs), topical CAIs, and prostaglandin analogues.

Surgery

For PCG eyes, surgery was carried out within 7 days of the baseline visit in 52.1% (n = 37 eyes), 14 days in 81.7% (n = 58 eyes), and 28 days in 90.1% (n = 64 eyes). Overall, it took around 18 days on average from the baseline visit to the first surgery (SD, 30.5 days; median, 7 days; IQR, 7.0 days) (Table 6).

Table 6 Management of Childhood Glaucoma or Glaucoma Suspect Eyes
Full size table

Of the PCG eyes that had surgery, 67.6% (n = 48) had only one glaucoma surgery. Of the 32.4% (n = 23) of eyes that had more than one glaucoma surgery, 29.6% (n = 21) had two operations, 1.4% (n = 1) had three, and 1.4% (n = 1) had four total operations per eye (Table 6).

The initial surgical procedure of choice for PCG eyes that underwent surgery was combined trabeculotomy-trabeculectomy (CTT) in 43.7% (31/71 eyes), followed by trabeculectomy 32.4% (23/71), goniotomy 22.5% (16/71), and trans-scleral cyclophotocoagulation (CPC). Primary glaucoma drainage device (GDD) surgery and trabeculotomy were not the first-line surgery for any PCG eyes (Fig. 2).

Fig. 2
figure 2

Initial Surgery for PCG eyes. CTT = Combined trabeculotomy-trabeculectomy, GDD = Glaucoma Drainage Device, CPC = trans-scleral cyclophotocoagulation

Full size image

Of 71 PCG eyes treated surgically, 23 eyes underwent more than 1 surgery (26 procedures), most underwent CTT (n = 12, 52.1%), followed by trabeculectomy (n = 6, 26.1%), GDD (n = 4, 17.4%), CPC (n = 3, 13.0%), and goniotomy (n = 1, 4.3%) (Fig. 3).

Fig. 3
figure 3

Secondary surgery for PCGs. CTT = Combined trabeculotomy-trabeculectomy, GDD = Glaucoma Drainage Device, CPC = trans-scleral cyclophotocoagulation

Full size image

Glaucoma suspect

There were 40 (22.1%) eyes with glaucoma suspect, majority of them 28 (70.0% of total glaucoma suspect eyes) were managed conservatively. While 30.0% (n = 12) of eyes were managed with medication (Table 6).

Secondary childhood glaucoma

Thirty-seven (20.4%) eyes had secondary childhood glaucoma, of which who had treatment record, all of them were treated medically (Table 6).

Juvenile open-angle glaucoma

Twenty-eight (15.5%) eyes had JOAG, and 19 (67.8%) of those were treated medically. Surgery was performed in 20.0% (n = 7) (Table 6).

Final visit clinical assessment

Of the 181 eyes with childhood glaucoma, 111 (61.3%) eyes had final visit quantitative VA (Table 4) and 130 (71.8%) eyes IOP records (Table 5).

Visual acuity

Final visit quantitative VA was recorded in 61.3% (n = 111 eyes) of all childhood glaucoma eyes (n = 181) and in only 23.7% of PCG eyes (considering age at diagnosis). The overall mean VA of the 111 eyes that had a quantitative VA at the final visit was 0.94 logMAR (SD, 1.11) (Table 4). When assessing only eyes with both baseline and final visit quantitative VA, there was a non-statistically significant deterioration in mean quantitative VA from baseline compared with final visit for the group overall (mean logMAR VA difference = 0.01, 95% confidence interval [CI], -0.09–0.06; P = 0.745, paired t test). For eyes with PCG, there was statistically significant deterioration (mean logMAR VA difference = -0.26, 95% CI, -0.5—-0.02; P = 0.033, paired t test). Which could be because of inappropriate documentation or because of the nature the study design and it needs prospective study. Furthermore, for eyes with JOAG there was a non-statistically significant deterioration in mean quantitative VA (mean logMAR VA difference = -0.15, 95% CI, -0.36—0.07; P = 0.17, paired t test). For eyes with secondary glaucoma, there was statistically significant improvement (mean logMAR VA difference = 0.18, 95% CI, 0.01—0.35; P = 0.033, paired t test) while for glaucoma suspect there was a non-statistically significant improvement (mean logMAR VA difference = 0.04, 95% CI, 0.02—-0.01; P = 0.132, paired t test) (Table 4).

Intraocular pressure

IOP was successfully controlled in 85.4% (111/130) of the eyes at the final visit, with 43.8% of complete and 41.5% of qualified success (Table 7). In contrast, 14.6% of failed cases had IOPs greater than 21 mmHg.

Of the 57 PCG eyes who had final visit IOP record, 78.9% of them had successful IOP control (complete 64.9% and qualified 14.0%). While IOP > 21 mmHg was present in 21.1% of the failed eyes.

For JOAG, 91.3% (21/23 eyes) had successful control (complete 21.7% and qualified 69.6%). For eyes with secondary glaucoma, 83.9% (25/29) had successful IOP control (complete 3.2% and qualified 80.6%). While all of glaucoma suspect eyes had a successful IOP control (complete 73.7% and qualified 26.3%) (Table 7).

Table 7 Intraocular Pressure Outcomes (Minimum 6-Month Follow-Up)
Full size table

With regard to IOP reduction, for all eyes with IOP records at final follow-up visit, mean IOP reduced from 37.1 mmHg at baseline to 16.8 mmHg (mean IOP reduction = 20.3 mmHg; 95% CI, 17.9–22.7; P < 0.001, paired t test). The PCG eyes had a mean IOP reduction of 24.5 mmHg (95% CI, 20.7–28.2, P < 0.001, paired t test), eyes with JOAG had a mean IOP reduction of 25.7 mmHg (95% CI, 20.0–31.3; P < 0.001, paired t test), and eyes with secondary glaucoma had a mean IOP reduction of 17.1 mmHg (95% CI, 17.0–34.1; P < 0.001, paired t test) (Table 5).

Discussion

Childhood glaucoma is a vision-threatening disease characterized by elevated intraocular pressure (IOP)-related damage to the eye caused by a variety of conditions. IOP control is critical for optimal visual outcomes and can be achieved through both medical and surgical therapy. This study analyzed the profile of childhood glaucoma among patients presented to the Jimma Medical Center from September 2019 to August 2022.

During the 3-year study period PCG was the most common type of childhood glaucoma (42%), consistent with previous studies [11,12,13,14]. The mean age at presentation of PCG patients was 2.7 years old, which is significantly older than the mean age at presentation of 11 months in developed countries [15], however similar to reports in developing countries [16, 17]. Late presentation of PCG patients in the developing world is a well-known challenge [18]. Many factors contribute to this, including limited access to healthcare due to socioeconomic status, healthcare costs, physical distances required to travel to healthcare centers, and potential financial impact on parents' livelihoods.

In this study, only ≈ 3% of the patients had family history of childhood-onset glaucoma and, for most patients’ the history of consanguinity was unknown. This finding is smaller than a 20% positive family history of childhood-onset glaucoma observed in a retrospective study in USA [5]. This low prevalence is due to lack of proper detection and documentation.

Majority (94.4%) of PCG eyes in this study received glaucoma medications before surgery. Greater than a report from a multicenter, prospective study, where 57% of PCG eyes received antiglaucoma medication before surgery [19]. This is due to higher IOP at presentation in this study, increasing the use of antiglaucoma medications as temporizing measure before surgery. In this multicenter prospective study, topical CAI was used in 82.2%, topical beta-blocker in 50% and oral CAI in 2.7% of PCG eyes. In the current study, topical beta-blockers (100%) and systemic carbonic anhydrase inhibitors (76.4%) were the most frequent medications prescribed. Systemic CAIs prescribed in higher percentage of PCG eyes in comparison to this multicenter, prospective study [19], and in a retrospective study in Egypt [17]. This highlights how crucial it is to utilize drugs correctly while being mindful of any specific side effects they may have in children.

PCG is considered a surgical condition, and angle surgery is the first-line procedure, either as goniotomy, trabeculotomy with a trabeculotome probe, or an illuminated microcatheter or other filament to achieve 360-degree incisions [20]. However, primary CTT for PCG has been recommended in some patients who appear late and have a more severe phenotype [21,22,23] because it has a higher success rate for IOP control than trabeculotomy or trabeculectomy alone.

In this study, 93.4% of PCG eyes treated surgically. Majority of them underwent primary CTT as first line surgery, followed by trabeculectomy and goniotomy. Late presentation has been contributed to CTT being as a favored procedure. This finding is consistent with other reports in developing countries [16, 17, 24]. In centers in the United States, United Kingdom, Germany, Saudi Arabia, Singapore, and Israel, angle surgery alone was the first line, according to a report by Papadopoulos et al. [19].

In our study, about 22.4% of PCG eyes required medical treatment after surgery, with 1.24 mean number of antiglaucoma drugs (AGDs). This finding is smaller than the observed finding in a retrospective study in Egypt, 49.5% of PCG eyes required medical treatment after surgery, with 1.7 mean number of AGDs [17]. This signifies the higher surgical success rate of CTT in our center.

The mean final visit IOP of 17 ± 7.7 mmHg observed in our study is comparable to the mean final visit IOP of 16.2 ± 7.3 mmHg observed in a multicenter, prospective study of patients with PCG [19]. Additionally, it is comparable to the mean final visit IOP reported in a retrospective study from Egypt, which was 20.60 ± 3.03 mmHg [17].

With regard to success of childhood glaucoma management, considering VA outcome is more important. Achieving the goal of preserving visual function in children with glaucoma is influenced by factors other than IOP, such as corneal clarity, refractive status, and amblyopia, which also must be addressed. There was a statistically significant a mean logMAR VA deterioration of -0.26, (95% CI, -0.5—-0.02; p = 0.033, paired t test) in quantitative VA in PCG (albeit small number of eyes). Furthermore, the final quantitative VA was reported with refractive correction in only 5.3% of PCG eyes. The importance of ametropic correction (and amblyopia treatment) cannot be stressed enough if the child is to achieve his/her maximum visual potential. This is not to be underestimated, because better VA is associated with both higher functional visual ability and quality of life [25].

With regard to control of IOP ≤ 21 mmHg, there was a high degree of overall success for PCG (78.9%), with more complete than qualified success. Overall success for JOAG was 90.5% and secondary glaucoma was 86.2%, with more qualified than complete success, likely reflecting the greater use of medication as first-line therapy in these groups as opposed to surgery. This finding is similar to 72.9% overall success for PCG, with more complete than qualified success and, 83.7% overall success for JOAG and 76% for secondary glaucoma, with more qualified than complete success in a multicenter, prospective study [19].

Accurately assessing the prevalence of family history of childhood-onset glaucoma and consanguinity in patients with childhood glaucoma was difficult because of the lack of documentation. Another limitation of the study was being a single center report.

In conclusion, in this retrospective study of children < 18 years of age with glaucoma, the most common glaucoma was PCG and CTT was the most common surgery performed in these eyes. Steroid-induced glaucoma was the most common type of secondary type of secondary glaucoma; appropriate measures should be taken to avert this preventable glaucoma. One of a well-recognized challenge in developing countries, late presentation of patients with PCG, was also observed in our study. Which highlights, the need of increasing access to eye-care service and awareness of childhood glaucoma as a major public health issue. In addition, this study encourages the establishment of prospective studies and surgical trials in this field.

Availability of data and materials

The datasets used and/or analyzed during the current study available from the corresponding author on reasonable request.

Abbreviations

AGD:

Antiglaucoma drugs

CAI:

Carbonic anhydrase inhibitor

CCT:

Combined trabeculotomy–trabeculectomy

CGRN:

Childhood Glaucoma Research Network Classification

CPC:

Cyclophotocoagulation

EUA:

Examination Under Anesthesia

GDD:

Glaucoma Drainage Device

IOP:

Intraocular Pressure

JIA:

Juvenile Idiopathic Arthritis

JMC:

Jimma Medical Center

JOAG:

Juvenile Open-Angle Glaucoma

logMAR:

Logarithm of minimum angle of resolution

SD:

Standard Deviation

VA:

Visual Acuity

References

  1. Gould DB, John SW. Anterior segment dysgenesis and the developmental glaucomas are complex traits. Hum Mol Genet. 2002;11(10):1185–93.

    Article  CAS  PubMed  Google Scholar 

  2. Quigley HA. Number of people with glaucoma worldwide. Br J Ophthalmol. 1996;80(5):389–93.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Thau A, et al. New classification system for pediatric glaucoma: implications for clinical care and a research registry. Curr Opin Ophthalmol. 2018;29(5):385–94.

    Article  PubMed  Google Scholar 

  4. Weinreb RN, et al. Childhood glaucoma, vol. 9. Kugler Publications; 2013.

  5. Aponte EP, Diehl N, Mohney BG. Mohney, incidence and clinical characteristics of childhood glaucoma: a population-based study. Arch Ophthalmol. 2010;128(4):478–82.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Kong L, et al. An update on progress and the changing epidemiology of causes of childhood blindness worldwide. J AAPOS. 2012;16(6):501–7.

    Article  PubMed  Google Scholar 

  7. Moore DB, Tomkins O, Ben-Zion I. A review of primary congenital glaucoma in the developing world. Surv Ophthalmol. 2013;58(3):278–85.

    Article  PubMed  Google Scholar 

  8. Richardson K. Long term functional results infantile glaucoma. Trans Am Acad Ophthalmol Otolaryngol. 1967;71:833–6.

    PubMed  Google Scholar 

  9. Alodhayb S, et al. Update on pediatric glaucoma. In: Seminars in ophthalmology. Taylor and Francis; 2013.

  10. Day A, et al. The Royal College of Ophthalmologists’ National Ophthalmology Database study of cataract surgery: report 1, visual outcomes and complications. Eye. 2015;29(4):552–60.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Taylor RH, et al. The epidemiology of pediatric glaucoma: the Toronto experience. J AAPOS. 1999;3(5):308–15.

    Article  CAS  PubMed  Google Scholar 

  12. Bouhenni RA, Ricker I, Hertle RW. Prevalence and clinical characteristics of childhood glaucoma at a tertiary care children’s hospital. J Glaucoma. 2019;28(7):655–9.

    Article  PubMed  Google Scholar 

  13. Hoguet A, et al. A retrospective survey of childhood glaucoma prevalence according to Childhood Glaucoma Research Network classification. Indian J Ophthalmol. 2016;64(2):118.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Lopes NL, Gracitelli CP, Rolim-de-Moura C. Childhood glaucoma profile in a Brazilian tertiary care center using childhood glaucoma research network classification. J Glaucoma. 2021;30(2):129–33.

    Article  PubMed  Google Scholar 

  15. Papadopoulos M, et al. The British infantile and childhood glaucoma (BIG) eye study. Investig Ophthalmol Vis Sci. 2007;48(9):4100–6.

    Article  Google Scholar 

  16. Mdala S, et al. Profile of primary childhood glaucoma at a child eye health tertiary facility in Malawi. BMC Ophthalmol. 2022;22(1):1–6.

    Article  Google Scholar 

  17. Mokbel TH, et al. Childhood glaucoma profile in Dakahelia, Egypt: a retrospective study. Int J Ophthalmol. 2018;11(4):674.

    PubMed  PubMed Central  Google Scholar 

  18. Mandal AK, Senthil S. Childhood glaucoma surgery in developing countries. In: Surgical management of childhood glaucoma. Springer; 2018. p. 159–71.

    Chapter  Google Scholar 

  19. Papadopoulos M, et al. International study of childhood glaucoma. Ophthalmol Glaucoma. 2020;3(2):145–57.

    Article  PubMed  Google Scholar 

  20. Edmunds B, et al. Angle surgery: trabeculotomy. In: Surgical management of childhood glaucoma. 2018. p. 57–78.

  21. Al-Hazmi A, et al. Correlation between surgical success rate and severity of congenital glaucoma. Br J Ophthalmol. 2005;89(4):449–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Elder MJ. Combined trabeculotomy-trabeculectomy compared with primary trabeculectomy for congenital glaucoma. Br J Ophthalmol. 1994;78(10):745–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Mandal A, Nutheti R. Surgical outcome of primary developmental glaucoma: a single surgeon’s long–term experience from a Tertiary Eye Care Centre in India. Investig Ophthalmol Vis Sci. 2005;46(13):132–132.

    Google Scholar 

  24. Senthil S, et al. Profile of childhood glaucoma at a tertiary center in South India. Indian J Ophthalmol. 2019;67(3):358.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Dahlmann-Noor A, et al. Quality of life and functional vision in children with glaucoma. Ophthalmology. 2017;124(7):1048–55.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

The author would like to acknowledge Jimma University for supporting this study. The author also would like to acknowledge Shimelis Girma staff of Jimma University for revising the final manuscript.

Funding

No grant was obtained from any funding agent for this study.

Author information

Authors and Affiliations

  1. Department of Ophthalmology, Institute of Health, Jimma University, Jimma, Ethiopia

    Tarekegn Mulugeta, Guteta Gebremichael & Sufa Adugna

Authors
  1. Tarekegn Mulugeta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Guteta Gebremichael
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sufa Adugna
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Mulugeta wrote the main manuscript text and Gebremichael was the first advisor while Adugna was the second advisor. All authors reviewed the manuscript.

Corresponding author

Correspondence to Tarekegn Mulugeta.

Ethics declarations

Ethics approval and consent to participate

The study obtained ethical approval by the Institutional Review Board (IRB) of Jimma University Institute of Health (No.: JUIH/IRB/119/22) and conducted in accordance with the tents of the Declaration of Helsinki. Formal informed consent for this retrospective study was waived by IRB of Jimma University Institute of Health. Confidentiality of information was respected.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mulugeta, T., Gebremichael, G. & Adugna, S. Childhood glaucoma profile in a Southwestern Ethiopia tertiary care center: a retrospective study. BMC Ophthalmol 24, 31 (2024). https://doi.org/10.1186/s12886-023-03268-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12886-023-03268-7

Keywords

BMC Ophthalmology

ISSN: 1471-2415

Contact us